3D Global Biotech Income Statement

Financials in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun '25 Jun 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Revenue	324.87	265.69	20.63	13.64	11.08	13.26
Revenue Growth (YoY)	489.06%	1187.67%	51.23%	23.19%	-16.48%	-27.05%
Cost of Revenue	99.28	91.18	15.36	10.93	9.27	8.29
Gross Profit	225.59	174.51	5.27	2.72	1.8	4.97
Selling, General & Admin	55.19	42.54	29.53	29.53	26.41	19.68
Research & Development	43.13	43.27	38.6	39.48	37.6	35.62
Operating Expenses	98.65	86.02	68.13	69	64.01	55.3
Operating Income	126.94	88.49	-62.85	-66.29	-62.21	-50.33
Interest Expense	-0.91	-0.12	-0.18	-0.26	-0.26	-0.1
Interest & Investment Income	11.09	6.19	2.24	1.68	1.35	1.71
Currency Exchange Gain (Loss)	-12.73	1.3	0.02	-0.01	0	-
Other Non Operating Income (Expenses)	0.04	0.14	1.85	0.62	0.15	0.24
EBT Excluding Unusual Items	124.43	96	-58.92	-64.25	-60.97	-48.48
Gain (Loss) on Sale of Assets	-	0	-	-	-	-
Asset Writedown	-	-	-	-18.89	-	-
Other Unusual Items	0.07	0.07	-	0.01	-	-
Pretax Income	124.51	96.07	-58.92	-83.13	-60.97	-48.48
Income Tax Expense	-9.37	4.37	-0.96	-16.05	-1.26	-0.56
Net Income	133.88	91.7	-57.95	-67.09	-59.71	-47.92
Net Income to Common	133.88	91.7	-57.95	-67.09	-59.71	-47.92
Shares Outstanding (Basic)	76	69	56	55	54	54
Shares Outstanding (Diluted)	79	71	56	55	54	54
Shares Change (YoY)	31.23%	26.08%	2.32%	1.69%	0.77%	6.02%
EPS (Basic)	1.76	1.33	-1.03	-1.22	-1.11	-0.89
EPS (Diluted)	1.71	1.30	-1.03	-1.22	-1.11	-0.89
Free Cash Flow	89.09	14.91	-32.39	-35.33	-38.85	-23.26
Free Cash Flow Per Share	1.13	0.21	-0.58	-0.64	-0.72	-0.43
Dividend Per Share	0.530	0.530	-	-	-	-
Gross Margin	69.44%	65.68%	25.56%	19.91%	16.28%	37.49%
Operating Margin	39.07%	33.31%	-304.62%	-485.87%	-561.71%	-379.52%
Profit Margin	41.21%	34.52%	-280.87%	-491.73%	-539.10%	-361.34%
Free Cash Flow Margin	27.42%	5.61%	-156.99%	-258.98%	-350.81%	-175.38%
EBITDA	143.26	104.62	-46.49	-47.15	-42.46	-30.41
EBITDA Margin	44.10%	39.38%	-225.30%	-	-	-229.35%
D&A For EBITDA	16.32	16.13	16.37	19.14	19.75	19.91
EBIT	126.94	88.49	-62.85	-66.29	-62.21	-50.33
EBIT Margin	39.07%	33.31%	-	-	-	-
Effective Tax Rate	-	4.55%	-	-	-	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.